FDA-2013-P-0615 |
California State Speech-Language Pathology and Audiology and Hearing Aid Dispensers Board |
Application for Exemption from Preemption of Device Requirements |
2012/06/04 |
|
|
FDA-2022-P-1151 |
Mark Baker, President |
Request FDA to regulate electromagnetic radiation in the visible portion of the spectrum emitted by products that use Light Emitting Diodes and that these regulations set restrictions on spatial non-uniformity, chip-level peak luminance and peak radiance, spectral power distribution, and square wave flicker and that the regulations be designed to protect the physical and psychological health, safety, comfort, and civil rights of those who are negatively impacted by LED light |
2022/06/13 |
2022/11/06 |
|
FDA-2022-P-2724 |
Hooman Noorchashm MD, PhD |
Revoke the medical device classification of P4HB based products from Becton Dickinson and reclassify these to a "Biologicals" |
2022/11/01 |
|
|
FDA-2022-P-1632 |
Randall Steinmeyer |
Requests that the FDA remove the Association for the Advancement of Blood & Biotherapies regulatory authority over DNA testing and transfer said authority to the American Society of Crime Laboratory Directors and halt the sale of the so-called motherless paternity tests. |
2022/07/21 |
|
|
FDA-2021-P-1148 |
Marlene Keeling |
Requesting breast implant manufacturers and plastic surgeons who implant or explant breast implants to pay for heavy metal testing and oxidation states of platinum when a woman who has been implanted has been diagnosed with an autoimmune disorder, connective tissue disease, cancer including Breast Implant Associated Large Cell Lymphoma or has the symptoms of Breast Implant Illness and if a breast implanted woman is breastfeeding, breast milk must be tested for heavy metals and oxidation states of platinum |
2021/10/21 |
|
2022/03/15 |
FDA-2021-P-0582 |
James McKim, Ph.D., IONTOX, LLC |
Requests that FDA reconsider the final decision to decline to review EUA210385 in the public interest and in the interest of justice was received and processed under CFR 10.30 |
2021/06/03 |
|
2021/08/28 |
FDA-2021-P-0445 |
Janice S. Lintz |
Requesting the FDA to standardize the naming of hearing aid features and develop a rating system using international ANSI standards for the various hearing aid features |
2021/05/03 |
|
2022/09/05 |
FDA-2021-P-0424 |
Sam DeMarco |
Requesting that the FDA amend regulation 21 CFR §890.5150(b), Powered Patient Transport (all other power patient transport), to exempt the classification from premarket notification |
2021/04/30 |
|
2021/10/19 |
FDA-2020-P-2289 |
Consumers for - Loeb & Loeb, LLP and James N. Czaban |
Requests the FDA to refrain from issuing any Warning Letter, Untitled Letter, or "It Has Come to Our attention" (IHCTOA) letter, or from initiating any other form of enforcement action against manufacturer or marketer of Daily Wear Uniform (scrubs) |
2020/12/10 |
2021/05/20 |
|
FDA-2020-P-2060 |
Penn Avenue Law & Policy |
Requesting the FDA to take Additional Administrative Action with respect to the Agency's Policy on Screening and Surveillance Tests During the COVID‐19 Public Health Emergency. |
2020/10/07 |
2021/10/05 |
|
FDA-1994-P-0023 |
MiniMed Technologies |
Implantable infusion pump for insulin |
1994/07/15 |
2003/03/21 |
2004/12/02 |
FDA-2001-P-0128 |
Bio-Rad Laboratories |
Permit mfrs. to allow the use of symbols in IVD labeling |
2001/07/10 |
2002/01/10
2002/09/11 |
2003/11/18 |
FDA-2001-P-0158 |
Association of Disposable Device Manufacturers |
Regulate reprocessed single use as reusable medical devices |
2001/08/15 |
2002/02/11 |
2004/12/29 |
FDA-2001-A-0410 |
PA Department of Health |
Collection kits marketed by the Osborn Group, Inc. |
2001/08/24 |
2002/04/04 |
|
FDA-2001-P-0389 |
Kyper & Associates LLC |
To revoke compliance program 7383.003 for class III 510(k) pre-amendment devices |
2001/09/05 |
|
2003/03/13 |
FDA-2002-P-0255 |
St. Jude Medical |
Electronic labeling programmer/computer that implanted pulse generator |
2002/02/26 |
2002/09/11 |
2003/09/29 |
FDA-2002-P-0172 |
Nocona General Hospital |
To amend the MQSA standard and FOI act to allow facilities to respond and post responses to warning letters on the Internet. |
2002/06/12 |
2003/03/27 |
2003/10/21 |
FDA-2002-P-0079 |
Russell J. Thomsen, M.D. |
Over-the-counter sales for hand-held Doppler Fetoscopes |
2002/07/29 |
2003/01/24 |
2003/06/19 |
FDA-2002-P-0437 |
Richard Strolworthy |
To amend the FDA 510(k) policy to include disclosure & labeling requirements |
2002/10/08 |
|
2003/04/16 |
FDA-2002-P-0132 |
Zuckerman, Spaeder LLP |
To post responses to warning letters on the Internet |
2002/10/30 |
2003/03/27 |
2003/10/21 |
FDA-2003-P-0105 |
Mettler Electronics Corp. |
FDA to revoke the medical device tracking order for invusion pumps |
2003/03/14 |
|
2003/05/28 |
FDA-2003-P-0166 |
Associated Pharmacologists & Toxicologists |
Revoke approval for marketing of menstrual cups |
2003/04/18 |
|
2003/11/18 |
FDA-2003-P-0014 |
Tim Milburn, O.D. |
Contact Lens |
2003/06/24 |
|
2004/06/28 |
FDA-2003-P-0403 |
Peter M. Rothenberg, MD, MA |
Exemption for an accessory to an electrode cable |
2003/06/30 |
|
2003/08/14 |
FDA-2003-P-0275 |
Etymotic Research, Inc. |
Over-the-counter Hearing Aids |
2003/08/11 |
|
2004/02/13 |
FDA-2003-P-0342 |
GudHear, Inc. |
Professional and Patient Labeling for Hearing Aid Devices |
2003/08/11 |
|
2004/02/13 |
FDA-2003-P-0184 |
Russel J. Thomsen, M.D. |
Requesting FDA to reconsider decision on Over-the-counter sales for hand-held doppler fetoscopes |
2003/09/08 |
2004/03/08 |
2004/06/14 |
FDA-2003-P-0266 |
Endotec, Inc. |
Revoke the AIP on Endotec |
2003/10/10 |
2004/03/26 |
|
FDA-2003-P-0411 |
National Organization for Women. |
Silicone gel-filled breast implants |
2003/11/03 |
|
2003/12/03 |
FDA-2003-P-0124 |
Chemically Associated Neurological Disorders |
Silicone gel-filled breast implants.
|
2003/11/18 |
|
2003/12/04 |
FDA-2003-P-0278 |
Committee for Truth in Psychiatry |
Maintain ECT in Class III |
2003/12/10 |
|
2004/09/03 |
FDA-2004-P-0164 |
Billy Pierson |
Med Watch complaint |
2003/12/22 |
|
2004/04/06 |
FDA-2004-P-0407 |
Etymotic Research Inc. |
TV-TIP Sound Amplifier (WORD) |
2004/01/22 |
|
2004/07/20 |
FDA-2004-P-0103 |
BioRad |
Issue a written opinion stating that unified, truthful labeling for domestic and international sales is lawful |
2004/02/06 |
2004/07/08 |
2007/05/02 |
FDA-2004-P-0407 |
Gastroparesis and Dysmotilities Association |
Transfer Enterra Therapy from HUD to PMA |
2004/02/26 |
|
2004/11/04 |
FDA-2004-P-0417 |
Philips Medical Systems |
Exemption from the medical devices tracking requirements for Heartstream automated external defibrillators |
2004/04/06 |
|
2004/10/29 |
FDA-2004-P-0349 |
Computerized Thermal Imaging Inc. |
Requesting FDA to permit CTI to supplement the administrative record in connection with CTI's PMA approval |
2004/07/01 |
2004/09/15 |
2004/10/26 |
FDA-2004-P-0223 |
Russel J. Thomsen, M.D. |
Requesting FDA to hold a public hearings to consider the appropriate regulatory status for low output, hand-held dopppler fetoscopes. |
2004/07/26 |
|
2005/02/25 |
FDA-2004-P-0028 |
Hyman, Phelps & McNamara, PC |
Requesting FDA to require manufacturers of reprocessed single-use electrosurgical cutting and coagulation devices and accessories to submit validation data. |
2004/07/28 |
|
2005/11/03 |
FDA-2004-P-0100 |
City of Arlington Texas |
Advisory opinion regarding automatic eternal defibrillators |
2004/08/09 |
|
2005/03/15 |
FDA-2004-P-0203 |
Northwest Community Hospital |
FDA to take action toward medical device manufacturers regarding the interchangeability of medical devices with one another |
2004/08/18 |
|
|
FDA-2004-P-0285 |
Endotec, Inc |
Request to reclass from III to II the Non-Constrained Mobile Bearing Ankle Prostheses. |
2005/10/13 |
2006/04/11 |
|
FDA-2005-A-0248 |
Bill Pierson |
Requesting the FDA for an opinion regarding hip joint metal constraint |
2005/02/07 |
|
2005/08/02 |
FDA-2005-P-0052 |
RS Medical |
Requesting that FDA reclassify non-invasive bone growth stimulator from Class III to Class II |
2005/02/09 |
2005/08/01 |
2007/04/02 |
FDA-2005-P-0382 |
World Wide Medical Technologies |
FDA safeguard kits for treatment of prostate cancer that use bone wax |
2005/02/23 |
2005/08/16 |
2009/05/22 |
FDA-2005-A-0419 |
Jaeckle Fleischmann & Mugel LLP |
Concerns on 510(k) for a Medical Device |
2005/04/05 |
|
2005/11/08 |
FDA-2005-P-0261 |
International Myopia Prevention Association |
Misbranding of prescription distance glasses and contact lenses |
2005/05/02 |
2005/10/28 |
2006/08/02 |
FDA-2005-P-0067 |
Zuckerman Spaeder LLP |
Requesting disapproval of the silicone-gel filled breast implant products. |
2005/05/23 |
2005/12/05 |
2006/11/17 |
FDA-2005-P-0251 |
Life Measurement Operations |
Requesting a change of classification of Sonamet Body Composition Analyzer |
2005/05/23 |
2005/10/21 |
2007/07/02 |
FDA-2005-P-0070 |
Scientific Laboratory Products LTD |
Request to Change the classification of EEG electrodes from Class II to Class I
Supplemental information submitted by Petitioner
|
2005/05/31 |
2005/11/09
|
2007/07/02 |
FDA-2005-P-0205 |
Medtronic Xomed |
Request to reclassify Class III to II for the Lamicel Osmotic Cervical Dilator |
2005/07/26 |
|
|
FDA-2005-P-0136 |
Public Citizen's Health Research Group |
FDA to establish tighter regulations governing the process by which Medical Devices are reviewed and recalled |
2005/11/10 |
2006/05/25 |
2011/07/11 |
FDA-2005-P-0063 |
S. Maher |
Reclassification metal/metal hip prostheses from Class III to Class II |
2005/09/19 |
2006/03/15 |
|
FDA-2005-P-0262 |
CooperSurgical, Inc. |
Requesting to reclassify the MCCue CUBA Clinical Ultrasonic Bone Sonometry System |
2005/10/26 |
|
2006/04/05 |
FDA-2005-P-0324 |
Wright Medical Technology Inc. |
To deny approval of Smith & Nephew premarket approval application for the Birmingham Hip Resurfacing System. |
2005/11/01 |
2005/10/31 |
2006/05/12 |
FDA-2005-P-0197 |
C. Brown, Consumers for Dental Choice |
Initiate Transfer of Responsibility to Regulate/Classify Dental Amalgam |
2005/11/15 |
|
2006/10/26 |
FDA-2005-P-0375 |
C. Brown, Consumers for Dental Choice |
Withdraw Draft Regulation on Mercury Amalgam |
2005/11/16 |
2006/10/26 |
|
FDA-2005-P-0008 |
Planmed Oy |
Reclassification of Full Field Digital Mammography from class III to class II |
2005/12/21 |
2006/04/18 |
|
FDA-2006-P-0337 |
Alcohol Monitoring System |
Petition for the SCRAM Bracelet |
2006/01/25 |
|
|
FDA-2006-P-0140 |
Regulatory & Clinical Research Institute |
Reclassification of Tissue Adhesive for Soft Tissue |
2006/02/09 |
2006/08/23 |
2008/05/05 |
FDA-2006-P-0024 |
Chemically Associated Neurological Disorders |
Stay the approvable of any PMA's for silicone gel-filled breast implants |
2006/04/10 |
|
2006/11/17 |
FDA-2006-P-0460 |
Banner & Witcoff, LTD |
Initiate Administrative proceedings and enjoining the unlawful sale and distribution by International Tan Markers, Inc. |
2006/04/18 |
|
2008/03/14 |
FDA-2006-P-0088 |
Michael Patterson |
Stop LASIK Due to Informed Consent Problems |
2006/05/19 |
2006/11/06 |
2007/07/20 |
FDA-2006-P-0347 |
Michael Patterson |
Enforce the single-use requirement for all Microkeratomes and their components used by Lasik |
2006/05/19 |
2006/11/06 |
2007/07/20 |
FDA-2006-P-0287 |
Robert Habig, PhD, Clinical & Laboratory Standards Institute |
Amend practice of assessing the performance of medical device for determining in vitro susceptibility of bacteria or fungi to include CL SI |
2006/06/26 |
2006/12/22 |
2007/03/05 |
FDA-2006-P-0074 |
American Association of Neurological Surgeons |
Cranial Orthoses exempt from Class II |
2006/07/06 |
2007/01/02 |
2007/12/26 |
FDA-2006-P-0022 |
Bayer Corporation |
Removal of Labeling for Medisense Precision Advanced Diabetes Management System |
2006/08/08 |
|
2006/09/06 |
FDA-2006-P-0336 |
Regeneration Technologies, Inc |
Bone Heterograft Reclassification |
2006/08/17 |
2007/10/29 |
2007/10/25 |
FDA-2006-P-0021 |
Kerr Corporation |
Urge FDA to take Regulatory Action to Safeguard the Public from Violative Dental Device Distributed by Five Companies,
Including Devices Manufactured in Unregistered Facilities and/or Subject to Tampering |
2006/09/05 |
|
2007/01/08 |
FDA-2006-P-0143 |
Public Citizen |
Revoke FDA's Prior Approval of Vagus Nerve Stimulation(VNS) for management of Treatment-resistant Depression
(TRD) |
2006/09/06 |
2007/03/02 |
2020/05/25 |
FDA-2006-P-0141 |
John D. Stephens, M.D. |
Banning of Accu-Gender Blood Test |
2006/09/11 |
|
2006/10/12 |
FDA-2006-P-0149 |
Washington Legal Foundation (WLF) |
Medical Device Assays Developed by Clinical Laboratories Strictly for In-House (Homebrew) |
2006/10/02 |
|
2014/07/31 |
FDA-2006-P-0454 |
Jerry Staton |
Order the Church of Scientology to Clearly Disclose the Potential health hazards inherent in the use of the E-Meter and scientology's practice of "auditing." |
2006/09/19 |
2007/03/16 |
2008/02/05 |
FDA-2006-P-0075 |
Michael Patterson |
Stop approving LASIK devices or Ban Lasik Devices |
2006/12/18 |
|
2007/07/20 |
FDA-2006-P-0277 |
Michael Patterson |
Stop all approvals of medical devices used for implantable lens implants |
2006/12/18 |
|
2007/07/20 |
FDA-2007-P-0116 |
Dean Andrew Kantis |
Take steps to insure the safety of Americans regarding the misuses of Lasik |
2007/01/05 |
|
|
FDA-2007-A-0279 |
AFrame Digital, Inc. |
AFram MobileCare Monitor system is not a medical device and should not fall under the regulatory authority of the FDA |
2007/04/24 |
|
|
FDA-2007-P-0005 |
Association of Medical Device Reprocessors |
FDA to Take Action to Subject Certain Cardiac Surgery Devices to 510(k) Requirements |
2007/05/01 |
2007/10/29 |
|
FDA-2007-P-0120 |
HiFi DNA Tech |
Petitioner request that FDA reclassify the human papillomavirus (HPV) DNA nested Polymerase chain reaction (PCR) detection device from class III to class II (513(f)) |
2007/05/22 |
|
|
FDA-2007-P-0288 |
Clinical & Laboratory Standards Institute (CLSI) |
Clear new susceptibility test devices or modification of existing devices using Clinical and Laboratory Standards Institute (CLSI) interpretive breakpoints in those instances regarding susceptibility |
2007/06/08 |
2007/12/06 |
|
FDA-2007-P-0115 |
Clinical & Laboratory Standards Institute (CLSI) |
Request that CDRH allow 510(k) clearance of devices for antimicrobial susceptibility testing of Streptococcus pneumoniae with penicillin |
2007/06/29 |
2007/12/06 |
|
FDA-2007-P-0117 |
Health Care Without Harm |
Regulation or Guideline to Label Medical Devices that Leach DEHP Plasticizers |
2007/08/14 |
|
|
FDA-2007-A-0163 |
Alston & Bird LLP |
Advisory Opinion request for Mandatory Black Box warnings on all Bovine Thrombin Products |
2007/08/24 |
2008/02/20 |
2008/06/02 |
FDA-2007-P-0118
FDA-2008-P-0066 |
Thomas J. Quinn |
Strict and immediate enforcement of performance standards contained in: 21 CFR 10.20(g)(h) and 1020.33(c); 21 CFR 1040.10(h); 21 CFR 820.170 |
2007/08/27 |
|
2009/09/08 |
FDA-2007-P-0464 |
Ralph D. Childs |
Electronic Product Radiation Control |
2007/10/03 |
|
2009/09/08 |
FDA-2007-P-0184 |
Judy Slome Cohain |
Restore FDA approval to Tecsana Epi-no birth trainer and to remove the adverse event report on Tecsana Epi-No from FDA website |
2007/12/12 |
|
2008/08/08 |
FDA-2007-P-0417 |
Consumer's Union |
Require that all print and electronic advertisements, including Internet advertisements, for implantable devices such as knee, hip, heart valves, cosmetic implants, and other devices |
2007/12/17 |
|
2010/03/30 |
FDA-2008-P-0196 |
Carmel Pharma |
Withdraw Teva 510(k)s |
2008/03/25 |
2008/08/20 |
2011/04/04 |
FDA-2008-P-0197 |
W.J. Kennick |
Tomatis Electronic Ear |
2008/03/20 |
2008/09/12 |
2008/11/26 |
FDA-2008-P-0252 |
Richard W. Treharne, PhD |
Withdraw FDA Policy on Establishing Preamendments Status |
2008/04/21 |
|
2010/12/21 |
FDA-2008-P-0282 |
Pneumex, Inc. |
Request that FDA reclassify Pneumex's device known as the Pneu-Vibe-Trac device from 510(k) requirements |
2008/04/17 |
|
2008/06/18 |
FDA-2008-P-0159 |
Missouri State Board of Examiners for Hearing Instrument Specialists |
Application for Exemption from Preemption of Device Requirements |
2008/03/05 |
|
|
FDA-2008-N-0163/PRC |
Moms Against Mercury, et al. |
Reconsider the Classification of Dental Amalgam as Class II |
2009/09/03 |
|
2015/01/27 |
FDA-2008-N-0163/PRC |
Citizens for Health, et al. |
Reconsider the Classification of Dental Amalgam as Class II |
2009/09/03 |
|
2015/01/27 |
FDA-2008-P-0319 |
Lauranell H. Burch |
Ban the use of all Refractive Surgery Lasers for LASIK Surgery and Acknowledge and Enforce Remedy for the Misbranding of lasers used for LASIK |
2008/05/28 |
|
2009/07/16 |
FDA-2008-P-0353 |
Fuerst, Humphrey, Ittleman, PL |
Petition for Stay of Action under 21 CFR 10.35 (concerning HairMax LaserComb medical devices) |
2008/06/18 |
|
2008/10/03 |
FDA-2008-P-0388 |
Links Medical Products, Inc. |
Petition for Reclasssification Under 513(f) - Reclassify the Tablet Crusher and Pouch and collectively the Tablet Crushing System currently regulated under 21 CFR Part 880.6430, from Class I to Class II. |
2008/07/09 |
|
|
FDA-2008-P-0444 |
Codonics, Inc. |
FDA conduct an immediate inspection of the Datcard Systems, Inc. facilities, and that the PacsCube products, manufactured by DatCard Systems, Inc. be detained for a determination of seizure, injunction, and/or other appropriate relief |
2008/08/06 |
|
2011/04/19 |
FDA-2008-P-0531 |
University of Virginia Health System |
Petition to Ban Cornstarch Powder on Medical Gloves |
2008/10/02 |
2009/03/09 |
2018/04/04 |
FDA-2008-P-0533 |
Fuerst, Humphrey, Ittleman, PL |
Take Action to Address the Growth of Online/Internet Advertising of Drugs and Devices |
2008/09/26 |
|
|
FDA-2008-P-0585 |
Elliot Farber |
Artificial Eyes Lubricant |
2008/11/04 |
|
|
FDA-2008-P-0630 |
The Prescription Project |
Take Action to Address the Growth of Online/Internet Advertising of Drugs and Devices |
2008/12/08 |
2009/05/31 |
|
FDA-2008-A-0619 |
Jeffrey K. Shapiro |
Request for Section 9 Limitations on 510(k) Exemption Advisory Opinion |
2009/12/01 |
2009/07/06 |
2011/03/15 |
FDA-2008-P-0638 |
Genetech, Inc. |
Require that all in vitro diagnostic tests intended for use in drug or biologic therapeutic decision making be held to the same scientific and regulatory standards |
2008/12/09 |
|
2014/07/31 |
FDA-2009-P-0023 |
Electro Medical Systems Corp. |
Request that FDA (i) revoke 510(k) Number K072809 from FDA's Premarket Notification Database and (ii) recall the D-Actor Vibration Massage System from the U.S. Marketplace |
2009/01/14 |
|
|
FDA-2009-P-0094 |
American Association for Health Freedom |
Consider the Potential Risks of Exposure to Bisphenol-A for Dental Applications |
2009/02/18 |
2009/08/10 |
2022/05/26 |
FDA-2009-P-0105 |
Williams Kherkher Hart Boundas, LLP |
Petition for FDA (1) inspection of all facilities where Medtronic sprint fidelis leads were manufactured and (2) the withdrawal of PMAs for the Medtronic sprint fidelis leads retroactive to September 2004 |
2009/02/18 |
|
2010/05/18 |
FDA-2009-P-0117 |
Kimberly-Clark Health Care |
Petition to ban Cornstarch Powder on Medical Gloves |
2009/02/26 |
|
2017/10/16 |
FDA-2009-P-0150 |
Arthur K. Yellin |
Create a Separate Classification for Gloves used in Preparing and Administering Chemotherapeutic Drugs |
2009/03/18 |
|
2010/08/24 |
FDA-2009-P-0207 |
Thomas Quinn |
Request for Immediate Class One Recall of Philips Medical Devices |
2009/05/05 |
2009/11/27 |
2013/09/27 |
FDA-2009-P-0253 |
Scott A. Tolchin |
Petition for FDA to Inspect LASIK Cinics to Ensure Compliance with 21 CFR 803, Subpart C User Facility Reporting Requirements |
2009/05/25 |
|
2010/05/18 |
FDA-2009-P-0282 |
Pepper Hamilton, LLP |
Petition for FDA to Detain devices within the "Remote Medication Management Systems" device type |
2009/06/19 |
|
2009/12/10 |
FDA-2009-P-0305 |
Hygeia II Medical Group, Inc. |
Petition Seeking Clarification and Review of Labeling for Breastpumps and Mother/Baby Products in Contact with Human Breastmilk |
2009/07/01 |
|
2020/05/04 |
FDA-2009-P-0357 |
International Academy of Oral Medicine and Toxicology |
Petition to Ban Dental Amalgam or Classify the Device as Class III |
|
|
|
FDA-2014-P-023 |
Adaptive Engineering Inc. |
Exempt the Manually Operated Wheelchair Lift From the 510(K) Premarket Notification |
2014/02/24 |
|
|
FDA-2012-N-0378 |
BioElectronics Corporation |
Effective Date of Requirement for Premarket Approval for Shortwave Diathermy for All Other Uses |
2012/07/23 |
|
|
FDA-2011-P-0641 |
Michael Carome, Public Citizen's Health Research Group |
Request to Ban Marketing of Non-Absorbable Surgical Mesh Products Designed and Labeled for Transvaginal Repair of Pelvic Organ Prolapse |
2011/08/26 |
|
|
FDA-2011-P-0374 |
Lanny J. Davis & Assoc., Robert R. Hopper & Assoc. |
Request Investigation of 3M Corporation and Its Conduct in BacLite Clinical Trial "A Covered Clinical Study" |
2011/05/17 |
|
|
FDA-2010-P-0580 |
Ralph McBride |
Clarify Approval of Medtronic Insulin Pump (P980022/S13) |
2010/11/10 |
2011/04/14 |
|
FDA-2020-P-2008 |
Philips Respironics |
Requesting FDA to issue an exemption from the device tracking requirements under 21 C.F.R. Part 821 for the Care Orchestrator.
|
2020/09/23 |
2020/12/18 |
|
FDA-2020-P-2010 |
Philips Respironics |
Requesting FDA to issue an exemption from the device tracking requirements under 21 C.F.R. Part 821 for the Care Orchestrator Essence. |
2020/09/23 |
|
|
FDA-2020-P-1864 |
Kambiz Tajkarimi |
Requesting FDA to refrain from granting a 510(k) clearance or any other premarket clearance or approval to the Augmenta penile implant. |
2020/09/11 |
2021/05/17 |
|
FDA-2020-P-1831 |
Meenal Kheterpal |
Requesting the FDA to issue a determination on class labeling for all currently approved hedgehog inhibitors products. |
2020/08/31 |
|
|
FDA-2020-P-1181 |
Max D. Sterm
Todd & Weld LLP |
Request the FDA Stay Both of the two Effective Dates of FDA's Final Regulation Banning Electrical Stimulation Devices used to treat Self-injurious or Aggressive Behavior (the "Final Rule" or "Ban") Published in the Federal Register on March 6, 2020. |
2020/03/23 |
|
2020/09/10
2022/06/13
|
FDA-2020-P-1166 |
Eckert Seamans Cherin & Mellott, LLC
Michael P. Flammia |
Requesting the FDA to Immediately and Indefinitely Stay Both of the two Effective dates for its Final Regulation Banning Electrical Stimulation Devices ("ESDs") to Treat Self-injurious behavior ("SIB") or aggressive Behavior ("AB") |
2020/03/23 |
|
2020/03/27
2022/06/13
|
FDA-2020-P-1220 |
C Laser Inc.
Pattanam Srinivasan, M.D. |
Requesting the FDA 1) Overrule the Denial Order and Remove Srilas 7 from Automatic Class III to be placed in Class II (or I); 2) Recognize Srilas 7 as a "Non Significant Risk" Device for the Purpose of a Clinical Study and 3) Recognize Srilas 7 as a Breakthrough Device in Patient's Best Interest Consistent with FDA Own Written Communication Dated October 28, 2010 Granting the Device Expedited Review Status was Received on 03/20/2020. |
2020/03/20 |
|
2021/07/17 |
FDA-2020-P-1003 |
John Coleman, M.A., M.S., PH.D. |
Requests that the FDA Initiate Rulemaking Procedures to Require Premarket Clearance for all Models of Fever Thermometers Sold OTC in the U.S. |
2020/02/28 |
2020/06/08 |
|
FDA-2020-P-0945 |
Dr. Ernest C. Chisena M.D., M.S., Orthopedic Attending Surgeon; Jahangir S. Rastegar, Ph.D., Associate Professor Mechanical Engineering Department Stony Brook |
Request the FDA to Force Exogen-Bioventus to Prove that Ultrasound is Responsible for Enhancing Fracture Healing as Claimed in their PMA |
2020/02/25 |
2020/07/18 |
|
FDA-2020-P-0893 |
Fisher Wallace Laboratories, Inc., Kelly Roman |
Requests that the FDA withdraw the Final Order regarding CES Devices (the "Final Order"), and to Convene a new Neurological Devices Panel of the Medical Devices Advisory Committee to review all Available Valid Scientific Evidence of Safety and Effectiveness Pertaining to CES Devices |
2020/02/18 |
2020/07/23 |
2021/08/30 |
FDA-2020-P-0725 |
GBUK Group Ltd., Dr. Steve Curran |
Requesting the FDA to Remove the Requirement for the Medical Devices and Accessories Contained within Premarket Submission for K170371 to be Supplied with Adequate Directions for Use. |
2020/02/11 |
|
|
FDA-2020-P-0734 |
GBUK Group Ltd., Dr. Steve Curran |
Request the FDA to Remove the Requirement for Adequate Directions for use to be Supplied with the Medical Devices and Accessories listed in Premarket Submission for K170900. |
2020/02/11 |
2020/07/18 |
|
FDA-2020-P-0152 |
Hyman, Phelps & McNamara, P.C. on behalf of Coalition to Preserve Access to PGx Information |
In the Subject column insert the following: Petition regarding Pharmacogenetic (PGx) testing reports & allowing clinical labs to communicate gene-drug interactions, requests FDA to revise their Safety Communication & requests any other such policy communications to be done by rulemaking. |
2020/01/09 |
2020/06/08 |
|
FDA-2019-P-5048 |
Epstein Becker & Green, P.C. |
Requesting the FDA to refrain from asking a determination of certain subject devices' substantial equivalence to the IB-Stim (21 C.F.R. § 876.5340, product code QHH) without preclinical studies and at least one clinical trial establishing non-inferiority of the subject device to the IB-Stim in head-to-head evaluations. |
2019/10/29 |
2020/04/27 |
|
FDA-2019-P-3347 |
Sean Honard |
Requests that the FDA amendment to regulation 21 CFR §890.3690, Powered Wheeled Stretcher, to exempt the classification from premarket notification |
2019/07/11 |
|
2019/12/31 |
FDA-2019-P-1800 |
Boditech Med Inc. |
Requests that FDA take all Administrative Actions Required for Reclassification from class III to class II of Medical Devices Associated with Product Code NCD (Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis) |
2019/05/22 |
|
|
FDA-2019-P-2038 |
American Dental Association |
Requesting FDA pursuant to FD&C Act §302(a) [21 U.S.C. §332(a)], an Injunction against SDC from Manufacturing or Continuing to Manufacture and from Continuing to Distribute and Sell in Interstate Commerce SDC's Plastic Teeth Aigner and Dental Impression Material Products. |
2019/04/26 |
|
2019/05/30 |
FDA-2019-P-1800 |
Boditech Med Inc. |
Requests that FDA take all Administrative Actions Required for Reclassification from class III to class II of Medical Devices Associated with Product Code NCD (Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis) |
2019/04/14 |
|
2019/04/16 |
FDA-2019-P-1009 |
Rossman Law Group, PLLC |
Requests the Commissioner to make a determination under 21 U.S.C. 1604(b)(3) regarding whether Lima Corporate S.P.A. was Required to Register with the Secretary under 21 U.S.C. 360 and/or list the Hip Implant Device at issue with the Secretary under 21 U.S.C. 360(j) |
2019/03/04 |
|
2019/07/01 |
FDA-2018-P-4143 |
Aakash Agarwal |
Requesting the FDA Cease Clearing 510(k)s and approving PMAs for Reprocessing of Pedicle Screws and other Implantable Orthopedic Devices and Cease Clearing 510(k)s for Reusable Implantable Orthopedic Devices |
2018/10/31 |
2017/04/02 |
|
FDA-2018-P-3951 |
Chul-Hi Park, Ph.D. |
Requesting the FDA to Implement a Retroactive Regulatory Action to Remedy Deficiencies found in the 510(k) Process for the Surgical Stapler Devices |
2018/10/18 |
2019/04/16 |
2021/10/12 |
FDA-2018-P-3896 |
Chul-Hi Park, Ph.D. |
Requesting the FDA to Prevent Certain Categories of New Devices from Being Cleared for Marketing without Sufficient Proof of Safety and Effectiveness for Staple Line Leaks |
2018/10/13 |
2019/04/11 |
2021/10/12 |
FDA-2018-P-3843 |
Hoomad Noorchashm, MD, Ph.D. |
Requesting the FDA to Ban the use of Uncontained Laparoscopic Power Morcellators in Gynecological Operations |
2018/10/10 |
2019/06/24 |
2020/12/30 |
FDA-2018-P-3806 |
Dr. Greg Grillo, DDS |
Requesting the FDA to Regulate Oral Moisturizer Products that are marketed for Mitigation, Treatment or Prevention of Dry Mouth and that Linger in the Mouth |
2018/10/05 |
2019/04/02 |
2020/11/09 |
FDA-2018-P-3709 |
Jennifer Nelson |
Requesting the FDA to Reconsider the issue of Banning and Recall all Permanent Cautery Instruments (Spatula and Hook) for all Da Vinci Robotic Surgeries |
2018/09/28 |
2019/03/04 |
2022/07/12 |
FDA-2018-P-3372 |
The Ohio State University
Lynne Gauthier, PhD |
Requesting the FDA to Expand FDA 510(k) Exemption Status to all Small and Portable Sensors that can be used for Relaxation of Muscular Reeducation |
2018/09/05 |
|
2021/04/21 |
FDA-2018-P-3102 |
Richard M. Fleming, MD, JD |
Request that the FDA respond to the applicable pharmaceutical companies, mammography and nuclear camera producers to address profiting from the misinformation regarding redistribution of the Technetium-99m Isotopes Sestamibi and Tetrofosmin, address misinformation being promulgated by the nuclear camera companies reporting that their SPECT and PET cameras are "quantifying" disease. |
2018/08/08 |
|
2019/07/09 |
FDA-2018-P-2073 |
LMS Direct Research Foundation |
Requesting the FDA seriously revisit and reconsider the issue of banning all laproscopic and hysteroscopic power morcellators for all GYN surgeries. |
2018/05/30 |
2018/06/12 |
2020/12/30 |
FDA-2018-P-1469 |
Epstein Becker & Green, P.C. |
Requesting FDA from making a determination of certain subject devices' substantial equivalence to the NSS-2 BRIDGE (21 C.F.R. § 882.5896) without preclinical studies and at least one clinical trial. |
2018/04/10 |
2018/10/18 |
|
FDA-2018-P-0599 |
National Pediculosis Association, Inc. |
Requesting FDA to update the Website and other Educational Collateral for the LiceMeister Comb for the Management and Treatment of Head Lice |
2018/02/07 |
2018/09/26 |
2020/01/17 |
FDA-2017-P-6663 |
Dr. S. Albert Edwards |
Requests that FDA Investigate Edwards Lifesciences' Marketing, in Interstate Commerce the Myxo ET Logix 5100, Annuloplasty Ring 5110, during 2007 to 2009 without approved 510k or PMA |
2017/11/27 |
2018/04/26 |
2020/05/25 |
FDA-2017-P-5124 |
Hyman, Phelps & McNamara, PC |
Requesting FDA to Exempt OTC Denture Repair Kits a Class II Device from Premarket Notification Requirements of section 510(k) of the FDC Act. |
2017/08/22 |
|
2018/01/31 |
FDA-2017-P-4939 |
Chul-Hi Park, Ph.D |
Requesting FDA to take Administrative Action to Prevent Certain Categories of New Devices from being cleared for marketing without sufficient proof of Safety and Effectiveness |
2017/08/14 |
2018/05/21 |
2021/10/12 |
FDA-2017-P-4335 |
William Bonificio |
Request to Amend the Classification of Glutaraldehyde-based tooth desensitizers from devices to drugs, or revoke their current classification as devices |
2017/07/18 |
2018/04/16 |
2021/05/26 |
FDA-2017-P-3884 |
Riverain Technologies, LLC. |
513(e) Petition for Reclassification for Riverain Technologies Clear Read - Detect CADe Device from Class III (PMA Approval P000041) to Class II |
2017/06/14 |
|
2018/06/04 |
FDA-2017-P-3405 |
Michael Boggi |
Requesting the FDA to initiate rulemaking requiring home medical device manufacturers to protect against the mixing of two different individuals' data on a smart phone app or other similar software. |
2017/05/30 |
2017/11/02 |
2018/07/24 |
FDA-2017-P-3330 |
Anonymous |
Requesting FDA to reconsider or revoke 510K Pre-Market Notification K151763 |
2017/05/23 |
2017/11/17 |
2020/01/28 |
FDA-2017-P-3413 |
Salter Labs |
Reclassification for the EtC02 Tracheal Tube Adaptor (airway adaptor) Device from Class II to Class I (510(k) exempt) |
2017/05/23 |
|
|
FDA-2017-P-2561 |
STL International, Inc.
Neal Hartman, Regulatory Consultant |
§ 513(e) Petition for Reclassification of Hang Ups InvertAlign |
2017/04/24 |
|
2018/06/18 |
FDA-2017-P-2233 |
Mercury Free Dentistry |
Requesting the FDA to amend its mercury amalgam rule 74 FR 38686 to implement measures to end amalgam use in children under age 15, pregnant women and breastfeeding mothers. |
2017/04/07 |
2017/10/26 |
2022/05/26 |
FDA-2017-P-1226 |
INRange Systems, Inc. |
Petition requesting FDA take action to protect patient safety by detaining the product manufactured or sold by PharmRight Corporation under the product name "Livi" |
2017/02/27 |
|
2017/09/25 |
FDA-2017-P-1002 |
INRange Systems, Inc. |
Petition requests FDA detain the device marketed as "LUMMA." |
2017/02/15 |
|
2017/09/22 |
FDA-2017-P-0290 |
Malaysian Rubber Export Promotion Council (Embassy) |
Request the FDA to extend the effective date of a Final Rule (FDA-2015-N-5107) from January 18, 2017 to March 18, 2017 to allow shipments carrying lightly powdered gloves to make appropriate arrangements at the port of entry to either ship elsewhere or re-label and re-pack for distribution to non-medical markets in the United States. |
2017/01/17 |
|
2017/06/26 |
FDA-2016-P-4587 |
Mallinckrodt Pharmaceuticals |
Requesting the FDA (CDER and CDRH) to review the inhaled nitric oxide drug products and nitric oxide delivery systems |
2016/12/28 |
|
2017/05/26 |
FDA-2016-P-4094 |
Adapt Pharma Operations Ltd |
Requesting FDA (CDER and CDRH) to require proposed generic versions of Intranasal to provide specific data to support interchangeability. |
2016/11/29 |
|
2017/04/21 |
FDA-2016-P-3674 |
Consumers for Dental Choice
Charles G. Brown |
Requesting the FDA to warn against amalgam use in children, pregnant women, and other sensitive populations |
2016/11/02 |
2017/04/27 |
2022/05/26 |
FDA-2016-P-3195 |
Wood, Herron & Evens, L.L.P. |
Requesting the FDA to detain the devices marketed as MagnaTouch MRI Music System, Genesis Ultra MRI Music System and MagnAlarm. |
2016/10/06 |
2016/10/07 |
2017/03/08 |
FDA-2016-P-2559 |
Jonathan W. Emord, et. al. Emord and Associates, P.C. |
Requests that the FDA either promulgate a final regulation making electroconvulsive therapy (ECT) devices banned devices or maintain the Class III classification of the devices and issue a final order establishing the effective date for premarketapproval (PMA) for all ECT devices |
2016/08/25 |
2017/02/02 |
2018/12/21 |
FDA-2016-P-2497 |
Clinical Decision Support Coalition |
Requested FDA to issue a guidance document |
2016/08/18 |
2017/02/02 |
|
FDA-2016-P-2072 |
Pacific-Link Consulting |
Requesting FDA guidelines for the Optimal Dose and Pharmacokinetics for any Naloxone Containing Product Intended for the Emergency Treatment of Suspected Opioid Overdose in all settings (Including Non-Medical Settings) by Individuals |
2016/07/13 |
|
2016/12/08 |
FDA-2016-P-1955 |
Mallinckrodt Pharmaceuticals |
Requesting the FDA to formally designate INOMAX and the company's 510(k) cleared specialized delivery system, the INOmax DSIR Plus, as a drug-device combination product pursuant to 21 C.F.R. § 3.2(e) |
2016/06/30 |
|
2016/11/23 |
FDA-2016-P-1398 |
Hooman Noorchashm, MD, PhD |
Requesting that the FDA revoke FDA clearance of the Pneumoliner Containment System for use with Power Morcellators |
2016/05/31 |
2016/11/17 |
2020/12/30 |
FDA-2016-P-1303 |
Charles G. Brown
Mercury Free Dentistry |
Requesting FDA to require patient labeling for dental amalgams |
2016/05/19 |
2016/11/17 |
2022/05/26 |
FDA-2016-P-1115 |
Mostyn Law Firm |
Request the FDA to issue an immediate Class I recall of all BSC products made with counterfeit, Chinese resin. |
2016/04/06 |
2016/09/21 |
|
FDA-2016-P-1026 |
Germaine Laboratories, Inc. |
Requests FDA to exempt devices classified as "Method, Metallic Reduction, Glucose (Urinary, Non Quantitative)" in 21 CFR 862.1340, from the premarket notification requirement (510(k)) |
2016/03/21 |
|
2016/09/06 |
FDA-2016-P-0159 |
Biorex Labs LLC |
Requests FDA to exempt devices classified as "Method, Metallic Reduction, Glucose (Urinary, Non Quantitative)" in 21 CFR 862 .1340, from the premarket notification requirement (510 (k)) |
2016/01/07 |
|
2016/07/01 |
FDA-2015-P-4945 |
Ryszard Rokicki |
Request FDA to order Bayer to use petitioners patented methodology on Essure |
2015/12/21 |
2016/03/14 |
2018/05/09 |
FDA-2015-P-3876 |
World Alliance for Mercury-Free Dentistry |
Requests FDA to make the changes included in this Citizen Petition to FDA's mercury amalgam rule so that the rule will conform with the Minamata Convention on Mercury |
2015/10/20 |
2016/04/19 |
2022/05/26 |
FDA-2015-P-3778 |
Orthofix, Inc. |
Requests FDA to enact the proposed rule dated 4/19/2013 to facilitate implementation of the Universal Device Identification Regulation |
2015/10/16 |
2016/04/11 |
2016/08/02 |
FDA-2015-P-3365 |
Inrange Systems, Inc. |
Requests FDA to detain Life Integrating Technologies product Lumma |
2015/09/18 |
2015/12/16 |
2015/12/16 |
FDA-2015-M-1065 |
Reed Smith LLP |
Reconsideration of PMA Approval of AutoSPray Dural Sealant |
2015/09/14 |
2015/10/16 |
2019/12/18 |
FDA-2015-P-3364 |
Leroy L. Hamilton, Ph.D. |
Request FDA to Complete and return "return receipt" postcards when they receive Certified or Registered letters with the green return receipt postcards attached |
2015/09/08 |
2016/06/21 |
2018/04/16 |
FDA-2015-P-3107 |
DuVal & Associates on behalf of Ferrosan Medical Devices A/S |
Requests FDA refrain from taking further action to reclassify collagen-based absorbable hemostatic devices |
2015/08/25 |
2016/01/21 |
|
FDA-2015-P-3108 |
DuVal & Associates on behalf of Ferrosan Medical Devices A/S |
Requests FDA refrain from taking further action to reclassify collagen-based absorbable hemostatic devices |
2015/08/25 |
|
2021/09/29 |
FDA-2015-P-2854 |
Olsson Frank Weeda Terman Matz on behalf of Provensis Ltd. |
Requests FDA withdraw approval of Premarket Approval Number P140018 for the VenaSeal® Closure System |
2015/08/05 |
|
|
FDA-2015-P-2820 |
Alston and Bird (the Center for Responsible Science) |
Requests FDA modify existing regulations that govern requirements for INDs, IDEs, and NDAs |
2015/08/03 |
2016/03/11 |
|
FDA-2015-P-2481 |
SweetSpot Diabetes Care, Inc. |
requesting reclassification of diabetes data management software devices from class II to class I |
2015/07/15 |
|
2019/11/07 |
FDA-2015-P-2375 |
Public Citizen Health Research Group |
Requests that FDA withdraw approval of Seprafilm Bioresorbable Membrane, premarket approval application number P950034, and initiate a mandatory recall of this product |
2015/07/07 |
2015/10/02 |
2021/01/29 |
FDA-2015-P-1924 |
Hunton and Williams LLP |
Requesting FDA issue an order declaring Zeltiq CoolSculpting System to be NSE |
2015/05/29 |
2015/10/08 |
2016/03/14 |
FDA-2015-P-1674 |
Kelly Quick, Globus Medical, Inc |
FDA not enforce 801.30(a)(1) for implants that were commercially distributed and held for sale to potential purchasers prior to the regulation implementation deadline identified by the FDA by device class |
2015/05/12 |
|
2020/02/26 |
FDA-2015-P-1197 |
Brian Orwat, Stryker Medical |
Request amendment to Regulation 21 CFR 890.3110 Electric Positioning Chair to Exempt Classification from Premarket Notification |
2015/04/13 |
|
2015/10/09 |
FDA-2015-P-0703 |
Sarah Salem-Robinson |
Issue Ban on Laparascopic Power Morcellators |
2015/03/05 |
|
2020/12/30 |
FDA-2015-P-0569 |
Marcus J. Susen & Justin Parafinczuk, Koch Parafinczuk & Wolf, P.A. |
Request that FDA take various actions against Bayer Healthcare Pharmaceuticals, Inc., and its subsidiaries regarding the "Essure" product |
2015/01/24 |
|
2015/03/26 |
FDA-2015-P-0095 |
Mark DuVal, DuVal and Assoc. (Leonhard Lang, GmbH) |
Request that the FDA grant an exemption from the medical device tracking requirements recently ordered |
2015/01/09 |
|
|
FDA-2015-P-0051 |
Christopher E. Bossi, Inrange Systems, Inc. |
Take action to protect patient safety by detaining the product manufactured or sold by; PharmRight Corporation under the product name "Livi" |
2015/01/06 |
|
2015/03/02 |
FDA-2015-P-0014 |
Edward L. Boshnick, O.D.; Roger D. Davis, Ph.D.; Richard B. Smith, Ph.D. |
Request that the FDA add a black box warning concerning the high incidence of induced visual symptoms to the device labeling of all excimer lasers used in laser eye surgery presently on the market in the U.S. |
2015/01/05 |
2015/06/18 |
2022/09/05 |
FDA-2014-P-0724 |
Barbara Spohn-Lillo, Rocky Mountain Anaplastology Inc. |
FDA to Consider Barbara Spohn-Lillo as a Clinical Practitioner and Exempt Rocky Mountain Anaplastology, Inc. from Device Registration and Listing |
2014/11/03 |
2015/04/30 |
2016/08/30 |
FDA-2014-P-0687 |
Margaret Moline |
Requesting FDA to revoke import alerts EPFX device |
2014/10/31 |
2014/04/22 |
2016/08/17 |
FDA-2014-P-1673 |
Tia Gonnella |
Request that the Commissioner of Food and Drugs amend the current content and format of High Level Disinfectant characterization for use with semi critical items employed in the healthcare setting |
2014/10/23 |
2014/12/22 |
|
FDA-2014-V-1503 |
Timothy J. Connors, Integra LifeSciences Corporation |
Approve a variance request that considers the device as a compliant system consisting of the electrode connected to the Integra EEG cable (as opposed to considering only the electrode) |
2014/10/02 |
2015/03/30 |
2015/05/22 |
FDA-2011-P-0022/PRC |
Waxler Regulatory Consultancy LLC |
Request that FDA Withdraw Premarket Approvals for all LASIK Excimer Laser Devices & Issue a Voluntary Recall of These Devices - Reconsideration Petition |
2014/09/02 |
2015/01/23 |
2016/10/26 |
FDA-2014-P-0919 |
Shumaier |
FDA withdraw its draft guidance regarding Regulatory Requirements for Hearing Aid Devices and Personal Sound Amplification Products and refrain from taking further action that directly or indirectly restricts availability of hearing assistive devices and personal sound amplification products |
2014/07/01 |
2014/12/23 |
2021/10/23 |
FDA-2014-P-0831 |
OrthoFix |
FDA not enforce 801.30(a)(1) for instruments in the control of third parties, provided labeling activities took place prior to the regulation implementation deadline identified by the FDA by device class |
2014/06/20 |
2014/12/17 |
2019/07/16 |
FDA-2014-P-0825 |
OrthoFix |
Requesting that the FDA not enforce 801.30(a)(1) for implants in the control of third parties provided labeling activities took place prior to the regulation implementation deadline identified by the FDA device class. Also requests that FDA refrain from requiring relabeling for product labeled prior to regulation implementation deadline and its 3 year implementation period |
2014/06/19 |
2014/12/17 |
2019/07/16 |
FDA-2014-P-0802 |
Moon T. Kwon |
FDA withdraw its draft guidance and refrain from taking any action affecting personal sound amplification products and cease further efforts to expand the scope of the generic device known as a hearing aid |
2014/06/17 |
2014/07/22 |
2021/10/23 |
FDA-2014-P-0654 |
Edwards Life-Sciences |
FDA grant a variance from specific quality system requirements for the delivery systems and accessories of the SAPIEN XT THV |
2014/05/20 |
|
|
FDA-2014-P-0445 |
Robert Larry Lytle |
Requests that FDA recognize that the private member associations created by Petitioner deal only with PMA members (not with the public), that the lawful acts of the PMAs are generally immune from or beyond the scope and purview of FDA's laws and regulations. |
2014/04/14 |
2014/05/30 |
2016/11/15 |
FDA-2014-P-0427 |
Medicem Technology |
Reclassify Dilapan |
2014/04/10 |
|
2014/08/14 |
FDA-2013-P-0949 |
Garrett Skelly, Esq. |
Reconsideration - Amend External Prosthetic Order and Procedures and Classification of All External Prosthetic Devices in 21 CFR 890.3420 and 21 CFR 890.3500 to Read as Both "Prescription" and "OTC" in Particular C-Leg K991590 |
2014/04/08 |
|
2020/05/30 |
FDA-2014-P-0290 |
Leroy L. Hamilton |
Direct CDRH to Include Product Codes Where Appropriate in Notices & Other Information Published for Specific Categories of Medical Devices |
2014/03/10 |
|
2014/05/16 |
FDA-2014-P-0283 |
Leroy L. Hamilton |
Revise Form FDA 3429 to Indicate the Appropriate Classification of a Medical Device |
2014/03/06 |
|
2014/05/16 |
FDA-2022-P-3013 |
Hooman Noorchashm MD, PhD |
Refer Becton Dickinson and Company's deliberate concealment of a bacterial ingress and contamination breach defect, in that company's 510(k) cleared GENESIS line of Rigid Sterilization Containers, to the Department of Justice for violation of the False Claims Act |
2022/11/28 |
|
|